Non-clinical and clinical development of similar biological medicinal products containing low-molecular-weight heparins

  • Email
  • Help
Current effective version

Adopted guideline - Revision 1

Reference numberEMEA/CHMP/BMWP/118264/2007 Rev. 1
Published24/11/2016
Effective from01/06/2017
KeywordsLow molecular weight heparins, low molecular mass heparins, similar biological medicinal products, biosimilar, comparability, quality, non-clinical studies, clinical studies, extrapolation
DescriptionThis document lays down the non-clinical and clinical requirements for low molecular weight heparins (LMWHs, low molecular mass heparins, LMMH) containing medicinal products claiming to be similar to another one already marketed.


Document history

Revision 1

Current version

 

Adopted guideline

 

 

 

Draft guideline


Concept paper

Published: 24/11/2016

 

Effective from: 01/06/2017

 

Published: 31/01/2013


Published: 27/07/2011

First version

Adopted guideline


Overview of comments


Draft guideline


Concept paper

In operation: 01/10/2009 - 01/06/2017


Published: 17/11/2009


Published: 24/04/2008


Published: 24/01/2007


Related content


How helpful is this page?

Average rating:

 Based on 3 ratings

Add your rating:

See all ratings
1 ratings
0 ratings
0 ratings
0 ratings
2 ratings
    

Tell us more